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ABSTRACT
Multilocus sequence typing (MLST) has been used to characterise methicillin-resistant Staphylococcus aureus (MRSA) 
isolates into sequence types (STs) and together with SCCmec typing, form the clonal nomenclature for MRSA. MLST was 
conducted as per the standard protocol on ten out of 236 isolates collected previously from January to December 2009 
representing four different SCCmec types. Relationship analysis was performed with eBURST via the MLST website. 
Four unlinked ‘singleton’ STs were detected: ST30, ST239, ST772 and ST1178. Together with SCCmec typing, five MRSA 
clones were identified: ST30-IV, ST239-II, ST239-III, ST772-V and ST1178-IV. Clones ST239-III and ST30-IV are already 
established in Malaysian hospitals and in the local community, respectively. ST772-V is an emerging clone reported 
previously to have a propensity to displace pre-existing predominant clones. A clone involving the predominant ST in 
Malaysia (ST239) with SCCmec type II is the first of its kind to be identified. MRSA clones in our centre are very diverse 
and clone surveillance with large sample sizes should be undertaken as collaborative efforts between local institutions 
to maximise detection coverage.
Keywords: Methicillin-resistant  Staphylococcus aureus (MRSA); molecular characterisation; multilocus sequence typing 
(MLST); Staphylococcal cassette chromosome mec (SCCmec) 
ABSTRAK
Penjenisan jujukan multilokus (MLST) membolehkan isolat Staphylococcus aureus rintang methicilin (MRSA) dicirikan 
kepada jenis-jenis jujukan (ST) tertentu. Apabila digabungkan dengan jenis jujukan SCCmec masing-masing, tatanama 
antarabangsa bagi klon-klon MRSA ini dapat dibentuk. Kajian MLST dijalankan mengikut protokol piawai ke atas sepuluh 
daripada 236 isolat MRSA terpilih yang dikumpul dari bulan Januari hingga Disember 2009 dengan setiap isolat 
mewakili empat jenis SCCmec yang berbeza. Hubungan antara isolat tersebut dikaji menggunakan eBURST melalui 
laman sesawang MLST. Empat jujukan tunggal ST yang tidak berkait telah dikenal pasti iaitu ST30, ST239, ST772 
dan ST1178. Bersama-sama pencirian jujukan SCCmec masing-masing, lima klon telah dikenal pasti, iaitu ST30-IV, 
ST239-II, ST239-III, ST772-V dan ST1178-IV. Klon-klon ST239-III dan ST30-IV telahpun diketahui bertapak di hospital-
hospital di Malaysia (ST239-III) dan juga di dalam komuniti (ST30-IV). Klon ST772-V adalah klon yang dikenal pasti 
sebagai klon yang baru muncul dan berkebolehan untuk menggantikan klon paling dominan sedia ada. Klon baru yang 
melibatkan ST paling dominan di Malaysia (ST239) dengan jujukan SCCmec jenis II telah ditemui buat kali pertama. 
Kami mendapati pelbagai klon MRSA dipencilkan di hospital kami. Oleh itu, kami menyarankan supaya pengawasan 
yang berterusan melibatkan saiz sampel yang lebih besar perlu dijalankan dengan kerjasama dari institusi tempatan 
yang lain bagi memaksimumkan liputan pengesanan. 
Kata kunci: Kromosom kaset mec stafilokokal (SCCmec); penjenisan jujukan multilokus (MLST); pencirian molekul; 
Staphylococcus aureus rintang meticillin (MRSA)
INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) is 
a major cause of nosocomial infections worldwide and 
is also being recovered in the community. The mecA 
gene, responsible for its mechanism of resistance, 
encodes PBP2a, an acquired penicillin-binding protein 
that has low affinity for methicillin and other β-lactams 
(Chambers 1997). This methicillin-resistance mechanism 
is present in most clinical MRSA isolates, along with 
two other known methicillin-resistance mechanisms, 
namely hyperproduction of β-lactamases (McDougal & 
Thornsberry 1986) and modification of normal penicillin-
binding proteins (PBPs) (Tomasz et al. 1989). It is not 
present in methicillin-susceptible strains and is believed 
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to have been acquired from a distantly related species, 
although not yet determined (Hiramatsu et al. 2001). It is 
carried on a mobile genetic element, the staphylococcal 
cassette chromosome mec (SCCmec), of which eleven 
main types (types I–XI) with their respective subtypes have 
been distinguished up to the present time (International 
Working Group on the classification of Staphylococcal 
Cassette Chromosome elements 2013).
 MRSA isolates have been previously characterised 
from different hospitals or countries to identify strains 
that have established in several hospitals within a country, 
or those that have spread internationally. Multilocus 
sequence typing (MLST), a method developed by Martin 
Maiden and his colleagues at Oxford University, United 
Kingdom, characterises bacterial isolates unambiguously 
by using the sequences of internal fragments of seven 
housekeeping genes (Maiden et al. 1998). With the help of 
an online database, different sequences for each of the loci 
are assigned arbitrary allele numbers and the combination 
of the seven assigned numbers form the allelic profile, or 
the sequence type (ST) (Saunders & Holmes 2007). MLST 
was originally developed and has been validated for S. 
aureus and provides a discriminatory method allowing 
related strains recovered in different countries to be readily 
identified and easily compared (Enright et al. 2000). In 
conjuction with SCCmec typing, it has provided a common 
international nomenclature for MRSA strains (Ito et al. 
2001). MLST data may support infection control and can be 
used to trace nosocomial sources and transmission routes 
of bacterial pathogens (Ghaznavi-Rad et al. 2010) and may 
also be used to further investigate the evolutionary and 
population biology of the strains (Enright et al. 2002).
 Until recently, a relatively small number of major 
MRSA clones with epidemic potential have been reported 
worldwide. However, the detection of these major MRSA 
clones from various local centers has varied from one 
study to another. In our hospital, SCCmec types II, III, IV 
and V have been previously identified among 236 non-
repetitive MRSA isolates collected during the period of 
January to December of 2009 (Ainihayati 2010). Therefore, 
the objective of the present study was to characterise ten 
selected MRSA isolates representing members of each of 
the SCCmec types, by using MLST and BURST analysis 
(Based Upon Related Sequence Types) to determine clonal 
diversity of MRSA isolates in our hospital. 
MATERIALS AND METHODS
SAMPLING METHOD
Four SCCmec types were previously identified among 236 
MRSA isolates collected from January to December 2009; 
SCCmec type II (one isolate), III (223 isolates), IV (eight 
isolates) and V (four isolates). Ten isolates were selected 
for MLST from members of each of the SCCmec types by 
using the convenience sampling method, with the goal of 
sampling the same amount of isolates from each group. 
Three representative isolates from each SCCmec type were 
selected except for the SCCmec type II group, which only 
contained one isolate. Whenever possible, the priority for 
selection was given to isolates from sterile body sites and 
all the selected isolates originated from different locations 
within the hospital. 
 The one and only swab specimen harbouring SCCmec 
type II originating from the orthopaedic clinic (MRSA 747) 
was selected. Majority of isolates harboured SCCmec 
type III, which included many from sterile sites including 
blood, bronchoalveolar lavage, bone, cerebrovascular 
fluid, pus aspirates and tissue. However, we chose blood 
isolates over other types of invasive isolates. Three blood 
isolates were randomly selected and were made sure to 
originate from three different locations in the hospital; the 
isolates chosen were MRSA 11 (High dependency ward), 
MRSA 598 (General intensive care unit) and MRSA 782 
(Medical 3 ward). Three isolates were selected from the 
SCCmec type IV group comprising of a pus isolate from 
the Surgical 7 ward (MRSA 320), a nasopharyngeal aspirate 
isolate from the Paediatric 1 ward (MRSA 380) and a 
tracheal aspirate isolate from the Paediatric intensive care 
unit (MRSA 377). A blood isolate (MRSA 742) originating 
from the General intensive care unit was not selected to 
prevent the sharing of location with the previously selected 
MRSA 598, which was the only blood isolate from the 
General intensive care unit harbouring SCCmec type III. 
MRSA 377 and MRSA 380 were chosen at random, with 
both originating from two different hospital locations. 
The three selected isolates harbouring SCCmec type V 
comprised of two tissue isolates, both originating from the 
orthopaedic ward (MRSA 154 & 347) and a swab isolate 
originating from the endocrine clinic (MRSA 421). MRSA 
347 was selected as a replacement for the initially selected 
MRSA 431 (a blood isolate from the oncology ward) that 
was excluded due to failure to detect its ‘house keeping’ 
genes with polymerase chain reaction. Details on the ten 
selected isolates are summarised in Table 1.
 The above selected MRSA isolates were retrieved from 
stock cultures in the Microbiology laboratory, which are 
stored at -70oC on cryoprotectant beads. The beads of the 
respective selected MRSA were inoculated onto blood agars 
and were incubated overnight at 37°C. 
NUCLEIC ACID EXTRACTION AND PCR FOR 
THE MLST ALLELES
Five to ten single colonies of pure growth from the blood 
agar of each respective selected MRSA strains were picked 
for DNA extraction. DNA extraction was performed with 
the DNeasy Blood & Tissue kit (QIAGEN, USA) according 
to the manufacturer’s protocol. Quantification and purity 
of the DNA extracts were determined using the Nanodrop 
2000 Spectrophotometer (Thermo Fisher Scientific, 
USA). PCR amplification was performed for each of the 
housekeeping genes for each MRSA isolate using standard 
primers for S. aureus MLST (Saunders & Holmes 2007). 
The cycling protocol used was according to the TopTaq 
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PCR kit handbook (June 2010) (QIAGEN, USA). PCR 
optimisation was performed by determining optimum 
annealing temperatures for each of the seven housekeeping 
gene primers. 
DETECTION AND PURIFICATION OF PCR PRODUCTS
Gel electrophoresis was performed using 1.5% agarose 
gel to confirm the presence and the quality of the PCR 
products. Purification of the PCR products was performed 
with the QIAquick PCR Purification kit according to the 
manufacturers protocol (QIAGEN, USA). Quantification 
and purity of the PCR purification products were also 
determined using the Nanodrop 2000 Spectrophotometer 
(Thermo Fisher Scientific, USA). 
DNA SEQUENCING AND ALIGNMENT
DNA sequencing was performed for the purified PCR 
products according to the DNA sequencing kit protocol 
(Beckman Coulter, USA) on the Beckman Coulter CEQ 8000 
Genetic Analysis System (Beckman Coulter, USA). For the 
initial sequencing reaction runs, either one of the forward 
or the reverse strands were sequenced for each allele. 
Base calling accuracy was checked with the CEQ Sequence 
Analysis Module in conjunction with 4 peaks software 
(Nucleobytes Inc., USA). Sequencing was repeated for any 
unsatisfactory sequences together with the sequencing of 
their respective complementary strands. Satisfactory DNA 
sequences were only used for further analysis. Sequence 
alignment and trimming was performed with an online 
analysis tool (SDSC Biology Workbench, http://workbench.
sdsc.edu) using reference sequences (http://www.mlst.
net). ST was determined by comparing the allelic profiles 
with the database at the MLST website, which is hosted at 
Imperial College London and is funded by the Wellcome 
Trust (http://saureus.mlst.net). 
BURST AND PHYLOGENETIC ANALYSIS
Relationship analysis was performed with the aid of 
eBURST (v3) via the MLST website. The default eBURST 
setting was used to identify groups of related STs using 
the most stringent (conservative) definition, as proposed 
by the authors of eBURST, where all members were 
assigned to the same group must share identical alleles 
at six of the seven loci with at least one other member of 
the group. This group definition was used to analyse the 
relationship between the identified STs representative of 
the selected MRSA strains in this study, as well as to analyse 
the relationship of these STs against other STs already 
available in the S. aureus MLST database. A ‘population 
snapshot’ diagram was constructed, by changing the 
group definition setting in eBURST from the default value 
of 6/7 loci to 0/7 as per instructions on the website. A 
UPGMA dendrogram (unweighted pair group method with 
arithmetic mean) was also constructed via the website.
RESULTS
Four different sequence types (STs) were identified 
among the ten selected MRSA isolates. The sequence types 
identified are ST30 (n=1), ST239 (n=4), ST772 (n=3) and 
ST1178 (n=2). Along with their corresponding SCCmec 
types, five MRSA clones were identified; ST239-II (n=1), 
ST239-III (n=3), ST30-IV (n=1), ST772-V (n=3) and 
ST1178-IV (n=2) (Table 2).
RELATIONSHIP BETWEEN THE SELECTED MRSA STRAINS
The four different STs were shown to be unlinked ‘singleton 
STs’ by using the stringent eBURST definition (i.e. they 
do not share alleles in at least six out of the seven loci 
between STs, or even five out of the seven loci using the 
more relaxed group definition) (eBURST Version 3). This 
suggests that these STs belong to distinct groups and are 
distantly related from each other. The relationship of these 
STs is illustrated in Figure 1. 
RELATIONSHIP OF THE SELECTED MRSA STRAINS AGAINST 
OTHER S. AUREUS STRAINS IN THE MLST DATABASE
Using the default (stringent) definition of a group, analysis 
with eBURST shows that the four STs can be divided into 
three major groups, out of a total of 71 groups dividing 
all of the currently available STs in the S. aureus MLST 
TABLE 1. Selected isolates characterised in the study
No. Sample ID SCCmec type Sample type Origin
1
2
3
4
5
6
7
8
9
10
MRSA 747
MRSA 11
MRSA 598
MRSA 782
MRSA 320
MRSA 377
MRSA 380
MRSA 154
MRSA 347*
MRSA 421
II
III
III
III
IV
IV
IV
V
V
V
Swab
Blood
Blood
Blood
Pus
Tracheal aspirate
Nasopharyngeal aspirate
Tissue
Tissue
Swab
Orthopaedic clinic
High dependency ward
General intensive care unit
Medical 3 ward
Surgery 7 ward
Paediatric intensive care unit
Paediatric 1 ward
Male orthopaedic ward
Male orthopaedic ward
Endocrine clinic
*MRSA 347 was selected as a replacement for the initially selected MRSA 431 (a blood isolate from the oncology ward) that was excluded due to failure to 
detect its ‘house keeping’ genes by polymerase chain reaction
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TABLE 2. Allelic profiles, sequence types and MRSA clones identified
MRSA ID Allelic Profile* ST Clone
arcC aroE glpF gmk Pta tpi yqiL
MRSA 011
MRSA 154
MRSA 320
MRSA 347
MRSA 377
MRSA 380
MRSA 421
MRSA 598
MRSA 747
MRSA 782
2
1
2
1
1
1
1
2
2
2
3
1
2
1
181
181
1
3
3
3
1
1
2
1
1
1
1
1
1
1
1
1
2
1
4
4
1
1
1
1
4
22
6
22
12
12
22
4
4
4
4
1
3
1
1
1
1
4
4
4
3
1
2
1
10
10
1
3
3
3
772
30
772
1178
1178
772
239
239
239
239
ST239-III
ST772-V
ST30-IV
ST772-V
ST1178-IV
ST1178-IV
ST772-V
ST239-III
ST239-II
ST239-III       
*arcC: carbamate kinase; aroE: shikimate dehydrogenase; glpF: glycerol kinase; gmk: guanylate kinase; pta: phosphate acetyltransferase; tpi: triosephosphate-
isomerase; yqiL: acetyl coenzyme A acetyltransferase
FIGURE 1. A ‘Population snapshot’ diagram generated by eBURST showing the unlinked 
relationship between the four different STs identified among the selected MRSA strains. 
The areas of each of the circles indicate the prevalence of the ST in the input data
database. Each of the detected STs was examined in 
their respective groups, represented by figures drawn by 
eBURST (Figures 3, 4 & 5, respectively). The circles in 
the diagram represent the predicted primary founder of the 
group and the subgroup founder are coloured white and 
grey, respectively. The areas of each of the circles indicate 
the prevalence of the ST in the input data.
ST239
ST239 (MRSA 11, 598, 747 & 782) belongs to Clonal 
Complex 8 (CC8) within Group 1. ST239 is a single locus 
variant (SLV) of its subgroup founder, ST8. The predicted 
primary founder of Group 1 is ST5 (Figure 3).
ST1178
ST1178 (MRSA 377 & 380) belongs to CC5 within Group 
1. ST1178 is a SLV of ST5, the predicted founder of Group 
1 (Figure 3). Although ST1178 and ST239 are members 
of the same group, the eBURST diagram shows that both 
occur very distantly from each other.
ST772
ST772 (MRSA 154, 347 & 421) belongs to CC1 within 
Group 2. ST772 is a SLV of its subgroup founder, ST1. 
The predicted primary founder of Group 2 though, is 
ST15 (Figure 4).
ST30
ST30 (MRSA 320) belongs to CC30 within Group 3. ST30 
is the predicted primary founder of this group and currently 
has 139 SLVs (Figure 5).
DISCUSSION
Given the aforementioned sampling strategy, our study 
managed to demonstrate the presence of several different 
MRSA clones circulating in our hospital during the period 
of the sample collection. Of five clones identified, two 
clones shared SCCmec type IV (ST30-IV and ST1178-
IV), two were of the same sequence type but of different 
SCCmec types (ST239-II and ST239-III) and one was 
a distinct clone, ST772-V. The large differences in 
allelic profiles between the different sequence types 
were supported by eBURST analysis and the genetic 
distances demonstrated by the dendrogram (Figure 2); 
the sequence types belonged to distinct groups and were 
distantly related. Several studies have shown the presence 
of distantly related MRSA lineages (Enright et al. 2002; 
Fitzgerald et al. 2001; Musser & Kapur 1992), which have 
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diversified by the horizontal transfer of mec determinants 
(Enright et al. 2002).
 In 2010, ST239-III/IIIA was first reported to be the 
predominant clone in Malaysia (Ghaznavi-rad et al. 2010; 
Neela at al. 2010), similar to the findings of a larger Asian 
study (Chongtrakool et al. 2006). ST239-III also has 
a history of successful dissemination in other regions, 
leading to a diverse array of regionally prevalent clones 
(Wang et al. 2012). Although prevalence was not measured, 
the ST239-III clone was also detected in three out of the 
ten selected isolates in our study. ST239 is a SLV of ST8 and 
as shown in Figure 3, is currently assigned by eBURST 
as the putative ancestral genotype of two other subgroups 
within CC8. ST239-III was thought to be derived from 
an ST8-MRSA isolate that contained SCCmec type III, via 
a recombinational event in the arcC housekeeping gene 
(Enright et al. 2002). Currently, ST239 has many SLVs of 
its own and has been quoted by authors as the putative 
founder of its own clonal complex, i.e. CC239 (Ko et al. 
2005).
 An interesting finding in our study was the detection 
of ST239 with SCCmec type II. This ST239-II clone has 
not yet been reported in previous studies. Enright et al. 
(2002) reported that strains with the same sequence type 
can harbour different SCCmec types, for example ST5 
and ST8 was shown to harbor any of the SCCmec types 
I to IV, suggesting multiple mec introductions into S. 
aureus (Enright et al. 2002). The identification of ST239-
II and ST239-III in our study may demonstrate a similar 
phenomenon, although ST239-II may be postulated to be 
alternatively derived from an ST8 harbouring SCCmec type 
II via recombination. This clone was recovered from a skin 
swab specimen from a three-week-old post-operative leg 
wound with serous discharge, sent from the orthopaedic 
clinic. Although strains harboring SCCmec type II are 
reported predominant in certain Asian countries like Korea 
and Japan, none of those strains are ST239 (Chongtrakool 
et al. 2006).
 Besides hospital-acquired MRSA (HA-MRSA) as a well 
established cause of nosocomial infections, community-
acquired MRSA (CA-MRSA) is also now known to cause 
community-acquired infections, especially skin and soft 
tissue infections and necrotizing pneumonia (Boyle-Vavra 
& Daum 2007). However, the isolates included in our 
study were not categorised into HA- or CA-MRSA. Most 
CA-MRSA strains carry Panton-Valentine leukocidin (PVL) 
genes encoding a cytotoxin causing leukocyte destruction 
and tissue necrosis and possess a small mobile SCCmec 
type IV, V or VI, which are more easily transferable than 
the larger SCCmec types I, II and III found in HA-MRSA 
(Boyle-Vavra & Daum 2007). All three ST772-V clones 
in our study were recovered from three different patients 
with carbuncle, two of which originated from the male 
orthopaedic ward and one from the endocrine clinic. 
All three isolates were also previously found to carry 
PVL genes (Ainihayati 2010). These isolates are likely 
to be CA-MRSA based on the type of SCCmec harbored, 
presence of PVL genes and by the site of the infection (i.e. 
skin and soft tissue), all of which are associated with CA-
MRSA, although both isolates showed resistance towards 
penicillin, cloxacillin, erythromycin, ciprofloxacin and 
gentamicin, which is an antibiogram typically seen in 
FIGURE 2. UPGMA dendrogram (via saureus.mlst.net) showing sequence types, SCCmec types and the hospital 
location of MRSA strains included. This dendrogram is based on the pair-wise differences in the allelic profiles. 
The genetic distances between the sequence types are represented as numbers above the row lines. Although 
significant genetic distances are demonstrated between all sequence types, ST772 and ST1178 show the most 
similarity compared to among other sequence types, in which their alleles differ at four of the MLST loci
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HA-MRSA. Two previous local studies have also detected 
clones containing SCCmec type V, with one study that 
detected clones ST1-V and ST772-V only (Neela et al. 
2010) and the other detected clones ST1-V, ST7-V and 
ST188-V (Ghaznavi-Rad et al. 2010). Another local 
study conducted by Ahmad et al. (2009) did not identify 
any isolates harboring SCCmec type V in their larger 
collection of isolates involving more institutions spanning 
across the country during the same time period. Besides 
the sample size, the different geographical locations in 
which the different studies were conducted may have 
also affected the number of different clones identified, 
as clones detected have been shown to differ from one 
institution to the other, even for institutions located within 
the same region. 
 Afroz et al. (2008) initially reported PVL-gene carrying 
methicillin-susceptible Staphylococcus aureus (MSSA) in 
Bangladesh that were classified into ST88, ST772 and 
ST573, differing from those determined for their MRSA 
isolates. The presence of this ST772-MSSA may suggest 
that the ST772-V MRSA clone may have been derived 
from ST772-MSSA by acquiring SCCmec type V. ST772 
is a SLV of its subgroup founder ST1, belonging to clonal 
complex 1 (CC1) (Figure 4). MRSA ST772-V has also 
been reported previously in India and Malaysia (D’Souza 
et al. 2010; Neela et al. 2009) and subsequently in many 
other countries (Brennan et al. 2012). In India, ST772-V 
has been reported to be increasingly prevalent where it 
has spread into hospitals and together with ST22-IV has 
displaced the previously predominant nosocomial ST239-
FIGURE 4. eBURST diagram of Group 2. ST772 is highlighted in the box
FIGURE 5. eBURST diagram of Group 3. ST30 (highlighted in the box) is the predicted primary founder of this group
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III clone in that region (D’Souza et al. 2010). Though 
not detected in our study, the clones ST22-IV and ST22-
IVh have also previously been identified in local studies 
conducted by Ahmad et al. (2009) and Ghaznavi-Rad et 
al. (2010). EMRSA-15 (ST22-IV), an epidemic strain first 
reported in England, is also known to be the predominant 
strain among nosocomial strains in many countries (Shore 
et al. 2010). ST22 is easily spread due to the small size 
of SCCmec type IV, giving it the potential to eventually 
replace the currently predominant SCCmec type III strains 
in Malaysian hospitals (Ahmad et al. 2009). In our study, 
only three out of the eight isolates containing SCCmec 
type IV were characterised, thus the presence of ST22 
among the rest of our uncharacterised isolates containing 
SCCmec type IV could not be confirmed at the present 
time. ST30-IV was also identified in our study, which 
was also previously demonstrated to carry PVL genes 
(Ainihayati 2010). ST30-IV has also been reported to be 
the predominant CA-MRSA clone in Malaysia, with most of 
them carrying PVL genes (Ahmad et al. 2009). This MRSA 
clone is thought to have emerged from the introduction 
of SCCmec type IV into the successful ST30-MSSA clone 
(Enright et al. 2002). The detection of hospital-acquired 
ST30-IV as reported by Ahmad et al. (2009) is also a cause 
of concern. Another community-acquired SCCmec type IV-
carrying clone (ST59) becoming an important nosocomial 
pathogen in hospitals has also been reported (Huang et al. 
2007). On the other hand, in Japan, ST30-IV (predominant 
between 1979 to 1985) was shown to be replaced by ST5-II 
in the 1990s (Ma et al. 2006). 
 Two respiratory isolates from two different cases of 
bronchopneumonia in our study were identified as ST1178-
IV. One was recovered from the paediatric intensive care 
unit and the other from the paediatric ward. ST1178 is a 
SLV of ST5, which is the putative founder of clonal complex 
5 (CC5) (Figure 3). At the time of writing, there was only 
one ST1178-IV data entry currently deposited in the MLST 
database. This particular clone was recovered locally from 
another tertiary hospital and is a clinical isolate from a 
diabetic foot infection. No other published information yet 
exists regarding this particular MRSA clone at the present 
time.
 Due to some limitations, only ten samples were chosen 
randomly for this study to represent isolates from four 
SCCmec types. In contrast, other previous local studies 
have conducted sampling by way of selecting representative 
MRSA samples from different spa lineages or dominant spa 
types, as opposed to selecting SCCmec type representatives 
for MLST characterisation (Ghaznavi-Rad et al. 2010; Neela 
et al. 2010). To the best of our knowledge, our study is the 
first to undertake such an approach. MRSA isolates from our 
hospital however, have not yet undergone spa typing at the 
time of writing. Spa typing is useful in analysing hospital 
outbreaks and in identifying genetic changes that occur 
over a relatively short time span and more importantly has 
been suggested as the most suitable method to infer clonal 
relationships between isolates and when combined with 
PFGE would offer more discriminatory power for MRSA 
(Faria et al. 2008). Comprehensive sampling of isolates 
from each SCCmec type was done but this was challenging 
for isolates harbouring SCCmec type III, which had the 
largest number of isolates (223 isolates). In order to detect 
as many different clones as possible, each isolate selected 
originated from a different locality within the hospital, 
especially for isolates harbouring the same SCCmec type. 
The rationale for this measure was to reduce the likelihood 
of isolating an identical MRSA clone from different patients 
due to possible cross contamination or cross colonization 
among patients of the same ward. This may explain why 
clone ST772-V was isolated from both samples originating 
from the orthopaedic ward, as their inclusion was required 
as a replacement for the last isolate with this SCCmec type 
(MRSA 431 from the oncology ward) that had to be excluded 
due to technical difficulties. However, these two tissue 
isolates were recovered approximately two months apart 
from each other. Further typing by PFGE or spa typing, may 
be more discriminatory to further delineate the similarity 
between these isolates. Sampling may also be thwarted by 
the inter-ward movement of patients or colonised health 
care workers resulting in cross colonisation or cross 
contamination of patients across different wards when 
hand hygiene practices are lacking. Although additional 
analysis may be required, this may be the underlying 
reason for recovering clone ST1178-IV from both the 
Paediatric 1 ward and the Paediatric Intensive Care unit, 
which frequently see patient and staff movements from 
one ward to the other due to their close proximities.
CONCLUSION
Clonal diversity among the MRSA isolates included in our 
study was demonstrated by conducting MLST on different 
SCCmec type representatives, despite the limited number 
of isolates tested. eBURST analysis also demonstrated 
the distant relationships between the four detected STs 
among the ten isolates. The epidemic potential of the 
circulating clones identified calls for continuous clone 
surveillance and it is also important to observe changes 
in MRSA kinetics as elucidated from other studies. Joint 
efforts between different health institutions may also be 
necessary to maximise the detection coverage of different 
circulating MRSA clones in a country, as different clones 
may be identified from different institutions. 
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